Por favor, use este identificador para citar o enlazar este ítem: http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/8022
A New Vaccination Assessment Method and Strategy for COVID-19
james Michaelson
Acceso Abierto
Atribución-NoComercial
https://doi.org/10.1101/2023.04.14.23288579
https://www.medrxiv.org/content/10.1101/2023.04.14.23288579v1
Optimizing vaccination to reduce COVID-19 death remains a challenge. A new method, Gompertzian Analysis, examines numbers of infectious disease cases and deaths, by age, on log graphs, capturing COVID-19 Lethality (Deaths/Cases) by the Gompertz Mortality Equation. Gompertzian Analysis revealed that each of the first 4 Vaccination Events (primary and boosters) led to a ∼1/3rd reduction in COVID-19 Lethality. These vaccination reductions in COVID-19 Lethality were cumulative, persistent, and undiminished by variants, while vaccination’s impact on COVID-19 Infectivity (Cases/Population) was fleeting. Primary vaccination and 3 boosters gave an ∼85% reduction in COVID-19 Lethality, with projections suggesting ∼68% fewer deaths (∼267,000 to ∼85,000). Projections also suggest that 6 boosters may offer a ∼96% reduction in COVID-19 Lethality, to the familiar level of influenza, with a ∼91% reduction in COVID-19 deaths, to ∼25,000, fewer than automobile deaths. Gompertzian Analysis provides rational vaccination guidelines by age. Gompertzian Analysis points to a strategy molded by multiple vaccinations reducing COVID-19 Lethality, which is persistent, rather than focusing on reducing COVID-19 Infectivity, which is fleeting. Such a strategy, based on accumulating the necessary number of vaccinations (∼7), and possibly no more, would accept vaccination’s limited ability to prevent infection in exchange for its power to prevent death.
medRxiv
15-04-2023
Preimpreso
https://www.medrxiv.org
Inglés
Epidemia COVID-19
Público en general
VIRUS RESPIRATORIOS
Versión publicada
publishedVersion - Versión publicada
Aparece en las colecciones: Materiales de Consulta y Comunicados Técnicos

Cargar archivos:


Fichero Tamaño Formato  
A new Vaccination Assessment.pdf912.11 kBAdobe PDFVisualizar/Abrir